7:45 am Check-In & Light Breakfast
8:45 am Chair’s Opening Remarks
Identifying the Opportunities for New Bioactive Ingredients
9:00 am Exploring the Complexities of Human Breast Milk Components & Their Mechanisms of Action to Identify Core R&D Priorities
Synopsis
- Presenting the latest research on the understanding of human breast milk components
- Exploring how breast milk develops as the baby’s needs evolve with growth
- Elucidating the mechanisms of action of different components to inform key discovery and development decisions
9:30 am Demonstrating the Real-World Evidence of Innovative Infant Formulas
Synopsis
- Exploring case studies incorporating novel ingredients in infant formulas
- Reflecting on consumer adoption trends to inform the next generation of innovation
- Combining scientific and regulatory excellence to diversify infant formulas and stabilize supply chains
10:00 am Roundtable Discussion: Sharing the Priorities & Most Promising Opportunities for Bioactive Ingredients for Advancing Infant Formula
Synopsis
- Examining the current landscape of approved HMOs
- Discussing other bioactive ingredients in development where there’s potential for real-world application
- Highlighting how infant formula manufacturers evaluate future ingredient innovation
10:45 am Morning Break & Speed Networking
Synopsis
Our famous speed networking is the ideal opportunity to get face-to-face time with many of the brightest minds working in infant formula development and regulatory approval and introduce yourself to the attendees you would like to have more in-depth conversations with. Benchmark against industry leaders and establish meaningful relationships to pursue for the rest of the conference and beyond.
Advancing Ingredient Innovation from Discovery to Preclinical Development
11:45 am Improving the Selection & Usage of Animal Models to Generate High Quality Data
Synopsis
- Evaluating the use of piglets given consumer expectations and labeling limitations
- Addressing the growing ethical pushback against animal testing
- Harmonizing validated cell-based assays that are fit for purpose to ensure standardized results
12:15 pm Roundtable Discussion: Examining the Concept of Bioactive Ingredients & How This Translates to Safety Evaluations
Synopsis
- Discussing the existing risk assessment frameworks in the US, Europe and elsewhere
- Evaluating the meaning of bioactive ingredients and their application in infant formula
- Engaging on dossier compilation strategies
1:00 pm Networking Lunch
2:00 pm Understanding Parameters & Goals for Bioactivity Testing & Bioassay Development for Newer Ingredients
Synopsis
- Overcoming the lack of understanding of mechanisms of actions of bioactive ingredients in preclinical development
- Exploring how to effectively measure protein bioavailability in vitro
- Ensuring compatibility with various bioactive ingredients
2:30 pm Human Milk Probiotic: An Opportunity to Support Premature Infants by Microbiota Modulation
Synopsis
- Reviewing the main benefits of probiotic bacteria in human milk
- Presenting clinical data that demonstrated the possible mechanisms involved in infection protection and gut health
- Benefits of Human Milk Probiotic in premature: modulation of microbiota and description of health benefits for premature infants
3:00 pm Sharing Preclinical Updates to Improve the Bioavailability of Bioactive Ingredients
Synopsis
- Developing and producing lipid delivery systems of arachidonic and docosahexaenoic acids designed to improve the bioavailability of these two bioactive fatty acids
- Generating high-quality preclinical data to illustrate this improved bioavailability
- Sharing a snapshot of early clinical data